Literature DB >> 35112209

Financial distress and its associated burden in couples coping with an advanced cancer.

Juliet L Kroll1, Seokhun Kim2, Dalnim Cho3, Shiao-Pei Weathers4, Aileen B Chen5, Grace Smith3,5, Eduardo Bruera6, Kathrin Milbury2.   

Abstract

PURPOSE: In efforts to understand financial distress (FD) associated with advanced cancer care from the perspective of both patients with incurable disease and their spousal caregivers, we assessed FD in both members of the couple, identified symptom and quality of life (QOL) correlates, and examined the potential role of illness communication.
METHODS: Patients undergoing treatment for stage III/IV lung cancer or a grade III/IV primary brain tumor and their spousal caregivers (n = 76 dyads) completed measures of somatic and affective symptoms including FD, physical and mental QOL, and ease of engaging in illness communication. Patients and caregivers additionally rated their perception of each other's symptoms, including FD.
RESULTS: FD was endorsed by both patients (any FD 62.7%; high FD 24%) and spousal caregivers (any FD 64.7%; high FD 32.3%). Self-reported FD was significantly correlated (partial r = .52, p < .001) within couples. FD was associated with greater symptoms of anxiety (r = .29, p = .01; r = .31, p = .01), depression (r = 29, p = 01; r = .39, p = .001), and poorer physical QOL(r =  - .25, p = .03; r =  - .25, p = .001) for patients and caregivers, respectively. For patients, FD was additionally associated with poorer mental QOL(r =  - .44, p < .001). Caregivers accurately perceived patient FD, yet patients tended to underreport their caregiver's FD by almost an entire point (t = 2.8, p = .007). A 3-way interaction (FD X role X illness communication) revealed (b = .40, p = .041) that illness communication moderated the association between FD and physical QOL for spouses so that spouses who reported less ease of illness communication demonstrated a stronger association between financial distress and physical QOL (b =  - 2.08, p < .001) than those reporting greater ease of engaging in illness communication (b = .49, p = .508).
CONCLUSION: In the advanced cancer setting, FD is prevalent in both patients and their spousal caregivers and associated with psychological distress and poor physical QOL. Results suggest that optimal FD assessment should include patients and spouses, and spouse's ease of engaging with illness communication may be a potential target for future intervention studies.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Advanced cancer; Couples; End-of-life; Financial distress; Illness communication; Physical quality of life

Mesh:

Year:  2022        PMID: 35112209     DOI: 10.1007/s00520-021-06758-w

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  34 in total

Review 1.  The cancer family caregiving experience: an updated and expanded conceptual model.

Authors:  Barbara Swore Fletcher; Christine Miaskowski; Barbara Given; Karen Schumacher
Journal:  Eur J Oncol Nurs       Date:  2011-10-14       Impact factor: 2.398

2.  Environmental stress, psychological stress and allostatic load.

Authors:  Michael S Clark; Malcolm J Bond; Jane R Hecker
Journal:  Psychol Health Med       Date:  2007-01       Impact factor: 2.423

3.  Financial Toxicity of Cancer Care: It's Time to Intervene.

Authors:  S Yousuf Zafar
Journal:  J Natl Cancer Inst       Date:  2015-12-11       Impact factor: 13.506

4.  Psychological stress and disease.

Authors:  Sheldon Cohen; Denise Janicki-Deverts; Gregory E Miller
Journal:  JAMA       Date:  2007-10-10       Impact factor: 56.272

Review 5.  The impact of psychosocial stress and stress management on immune responses in patients with cancer.

Authors:  Michael H Antoni; Firdaus S Dhabhar
Journal:  Cancer       Date:  2019-02-15       Impact factor: 6.860

6.  Quality of life of caregivers of patients with advanced-stage cancer.

Authors:  Matthew M Clark; Teresa A Rummans; Jeff A Sloan; Andrus Jensen; Pamela J Atherton; Marlene H Frost; Jarrett W Richardson; J Michael Bostwick; Mary E Johnson; Jean M Hanson; Paul D Brown
Journal:  Am J Hosp Palliat Care       Date:  2006 Jun-Jul       Impact factor: 2.500

7.  Financial Toxicity in Advanced and Metastatic Cancer: Overburdened and Underprepared.

Authors:  Jason Rotter; Jennifer C Spencer; Stephanie B Wheeler
Journal:  J Oncol Pract       Date:  2019-03-07       Impact factor: 3.840

8.  Assessing cognitive dysfunction in breast cancer: what are the tools?

Authors:  Jason R Freeman; Donna K Broshek
Journal:  Clin Breast Cancer       Date:  2002-12       Impact factor: 3.225

9.  Quality of life of couples dealing with cancer: dyadic and individual adjustment among breast and prostate cancer survivors and their spousal caregivers.

Authors:  Youngmee Kim; Deborah A Kashy; David K Wellisch; Rachel L Spillers; Chiew Kwei Kaw; Tenbroeck G Smith
Journal:  Ann Behav Med       Date:  2008-04

10.  The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.

Authors:  Khalil Baddour; Mark Fadel; Meng Zhao; Michael Corcoran; Maryanna S Owoc; Teresa H Thomas; Lindsay M Sabik; Marci L Nilsen; Robert L Ferris; Leila J Mady
Journal:  Head Neck       Date:  2021-07-08       Impact factor: 3.821

View more
  2 in total

1.  Rural Family Caregiving: A Closer Look at the Impacts of Health, Care Work, Financial Distress, and Social Loneliness on Anxiety.

Authors:  Tanya L'Heureux; Jasneet Parmar; Bonnie Dobbs; Lesley Charles; Peter George J Tian; Lori-Ann Sacrey; Sharon Anderson
Journal:  Healthcare (Basel)       Date:  2022-06-21

2.  Lessening the Impact of Financial Toxicity (LIFT): a protocol for a multi-site, single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings.

Authors:  Stephanie B Wheeler; Caitlin B Biddell; Michelle L Manning; Mindy S Gellin; Neda R Padilla; Lisa P Spees; Cynthia D Rogers; Julia Rodriguez-O'Donnell; Cleo Samuel-Ryals; Sarah A Birken; Katherine E Reeder-Hayes; Victoria M Petermann; Allison M Deal; Donald L Rosenstein
Journal:  Trials       Date:  2022-10-03       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.